Blog2018-06-25T16:21:12-04:00

BLOG

Understanding the Importance of the NASDAQ Biotech Index (NBI)

Overview The NASDAQ Biotechnology Index (NBI) is a stock market index made up of NASDAQ-listed securities classified either as “biotechnology” or “pharmaceutical” by the Industry Classification Benchmark (ICB), an industry classification taxonomy launched by Dow Jones and FTSE in [...]

By |September 11th, 2020|Investor Relations, Investors|

Considerations if Your Company is Planning on Going Public Through a SPAC: Part 2

Positioning Your Company for Success Post SPAC or Reverse Merger When a company executes a reverse merger and/or becomes public via a Special Purpose Acquisition Company (SPAC) transaction, the newly public company will encounter investor relations challenges that differ [...]

By |September 4th, 2020|Investor Relations, IPO|

Considerations if Your Company is Planning on Going Public Through a SPAC: Part 1

Since January 2019, there have been about 15 US-listed SPAC IPOs compared to about 270 traditional IPOs. In our two-part series, we will explain the recent interest in SPACs and investor relations process and considerations. In Part I, we [...]

By |August 28th, 2020|Investor Relations, IPO|